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Summary
 
Numerous studies have examined T cell receptor (TCR) usage of selected virus-specific T cell
clones, yet little information is available regarding the stability and diversity of TCR repertoire
usage during viral infections. Here, we analyzed the V
 
b
 
8.1 TCR repertoire directly ex vivo by
complementarity-determining region 3 (CDR3) length spectratyping throughout the acute
lymphocytic choriomeningitis virus (LCMV) infection, into memory, and under conditions of
T cell clonal exhaustion. The V
 
b
 
8 population represented 30–35% of the LCMV-induced
CD8
 
1
 
 T cells and included T cells recognizing several LCMV-encoded peptides, allowing for
a comprehensive study of a multiclonal T cell response against a complex antigen. Genetically
identical mice generated remarkably different T cell responses, as reflected by different spec-
tratypes and different TCR sequences in same sized spectratype bands; however, a conserved
CDR3 motif was found within some same sized bands. This indicated that meaningful studies
on the evolution of the T cell repertoire required longitudinal studies within individual mice.
Such longitudinal studies with peripheral blood lymphocyte samples showed that (
 
a
 
) the virus-
induced T cell repertoire changes little during the apoptosis period after clearance of the viral
antigens; (
 
b
 
) the LCMV infection dramatically skews the host T cell repertoire in the memory
state; and (
 
c
 
) continuous selection of the T cell repertoire occurs under conditions of persistent
infections.
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V
 
iral infections often induce potent immune responses
associated with hyperplasia of T cells, which clear the
virus, undergo apoptosis, and return to homeostasis, leaving
the host with memory T cells that rapidly respond to the
pathogen on subsequent challenge (1). Although many
studies have examined the specificities and functions of se-
lected virus-specific T cell clones (2–5), little is known
about the diversity of the T cell repertoire in genetically
identical hosts responding to infection and how this reper-
toire changes during the transition between an acute infec-
tion and a memory response. The relationship between T
cell repertoires during primary and secondary viral infec-
tions and the evolution of the T cell response under con-
ditions of clonal exhaustion associated with persistent infec-
tions are also not well understood. For instance, Are there
changes in the T cell repertoire during the apoptotic phase
of the T cell response? How similar is the memory reper-
toire to that of the acute infection? Does T cell clonal ex-
haustion under conditions of high antigen dose eliminate
all or simply a subpopulation of responding T cells?
The strong T cell response during lymphocytic chori-
omeningitis virus (LCMV)
 
1
 
, strain Armstrong (LCMV-
ARM) infection of C57BL/6 mice is well characterized
and provides a useful system to study the evolution of the
TCR repertoire under conditions where antigen is cleared
and where an acute T cell response converts into a memory
response. The clone 13 variant of the Armstrong strain,
which differs from its parent strain by only two amino ac-
ids, disseminates broadly in vivo and results in persistent in-
fection and clonal exhaustion of CTL in high doses (6, 7).
The CD8
 
1
 
 T cell epitopes of LCMV-ARM and LCMV
clone 13 are the same (8), thereby enabling one to compare
the evolution of the LCMV-induced TCR repertoire us-
age during the LCMV-ARM and LCMV clone 13 infec-
 
1
 
Abbreviations used in this paper:
 
 CDR3, complementarity-determining
region 3; EXPT, experiment; GP, glycoprotein; LDA, limiting dilution
assay; LCMV, lymphocytic choriomeningitis virus; NP, nucleoprotein;
PB, peripheral blood; pCTL, precursor cytotoxic T lymphocyte; PEC,
peritoneal exudate cell; pTh, precursor T helper cell; PV, Pichinde virus.
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tions. For the rest of this paper, we use LCMV to represent
the LCMV-ARM parent strain, and clone 13 to represent
the disseminating variant.
The acute LCMV infection causes a logarithmic expan-
sion of LCMV-specific CTL, peaking at 
 
z
 
1/30 precursor
CTL (pCTL) per CD8
 
1
 
 cell at days 8–9 after infection (9).
These activated T cells become sensitized to activation-induced
cell death and die through apoptosis at days 10–14 after in-
fection (10, 11). Although there is a remarkable reduction
in the total number of CD8
 
1
 
 cells, the pCTL frequency
per CD8
 
1
 
 cell for each of three immunodominant peptides
drops only twofold and thereafter remains stable through-
out the lifetime of the mouse (9, 12). The LCMV-specific
CD4
 
1
 
 T helper cell precursors (pTh) peak at only about
1/600 CD4
 
1
 
 T cells, but reduction of pTh per CD4
 
1
 
 cell
and the stability of LCMV-specific pTh are similar to those
observed in the CD8 system (1). In contrast, the CTL
memory is lost under conditions of high doses of LCMV
clone 13 infection, which induces a transient antiviral CTL
response followed by a clonal exhaustion of the virus-spe-
cific CTL (7).
Kinetic studies on the pCTL frequencies to three immu-
nodominant peptides have suggested that the LCMV-spe-
cific T cell repertoire remains unchanged between day 7 of
infection and well into long term memory and that a high
frequency of LCMV-specific memory T cells is preserved
into memory. However, these data are dependent on the
ability of T cells to grow out in limiting dilution assays
(LDA), where in vitro manipulation in the functional assays
might introduce unknown biases. Recent work using tet-
rameric MHC molecules to quantify LCMV-specific T
cells supports our previous study, which concluded that
most of the CD8
 
1
 
 T cells included during LCMV infec-
tion are virus specific (13, 14). These studies also support
our LDA data that show a substantial skewing of the TCR
repertoire toward virus-specific cells in the memory state.
However, these studies define T cells in terms of their
specificity and do not evaluate any changes in TCR usage
that may develop during the progression of an infection.
Little is known about the relationship of multiple clones of
T cells to each other in a complex multiclonal immune re-
sponse directed against a number of immunodominant and
subdominant peptides.
To evaluate the dynamics of such a multiclonal T cell re-
sponse to a virus infection we have done a molecular anal-
ysis of the TCR repertoire directly ex vivo by complemen-
tarity-determining region 3 (CDR3) length spectratyping,
a technique initially developed by Pannetier et al. (15).
This technique consists of two major steps to analyze the
CDR3, which is encoded by the joining of V, D, and J
segments and defines much of the TCR specificity (16).
First, the RT-PCR reaction with specific V
 
b
 
 and C
 
b
 
primers competitively amplifies, from a bulk population of
T cells, TCR with specific V
 
b
 
 sequences but different
CDR3 regions. Second, the PCR products are further ana-
lyzed with different labeled J
 
b
 
 primers in a run-off reaction
to yield the size peaks for all the VDJ combinations. The
spectrum of size differences across the CDR3 region is
known as the spectratype. Since the relative intensity of a
given size peak is proportional to the amount of the non-
amplified RNA molecules, an increase in the height and
area of a particular peak signals expansion of T cell clones.
Therefore, one can obtain distinct CDR3 profiles to ana-
lyze for changes of the TCR repertoire during infection.
To examine the LCMV-induced T cell repertoire usage,
we analyzed the V
 
b
 
8.1
 
1
 
 T cell repertoire because it was
expanded vigorously during acute LCMV infection. It rep-
resents a substantial portion of the CD8
 
1
 
 T cell response
and includes T cells with a wide variety of specificities di-
rected against several virus-encoded peptides. Our data in-
dicate that genetically identical mice generate significantly
different T cell responses to the same antigens, albeit with
some preferential J
 
b
 
 usage and a conserved TCR motif.
This indicates that, unlike LDA and tetrameric MHC–pep-
tide analyses, spectratype comparisons of T cell receptors
between mice are uninterpretable and that individual mice
must be examined longitudinally for a meaningful analysis
of the evolution of T cell responses. We present here such
a longitudinal study, and our data support the concepts that
(
 
a
 
) no further selection of LCMV-induced T cell repertoire
occurs after the virus is cleared and during the apoptotic
phase of the immune response; (
 
b
 
) the LCMV infection al-
ters the host T cell repertoire dramatically and leaves it
with a high frequency of LCMV-specific T cells in the
memory state; and (
 
c
 
) evolution of the T cell response oc-
curs under conditions of clonal exhaustion associated with
persistent infection.
 
Materials and Methods
 
Virus Preparation.
 
The LCMV-A
 
rm
 
 strain and the AN3739
strain of Pichinde virus (PV) were propagated in baby hamster kid-
ney cells, as described previously (17). The highly disseminating
LCMV-A
 
rm
 
 clone 13 variant was obtained from Dr. M.B.A. Old-
stone (Scripps Clinic and Research Foundation, La Jolla, CA) (8).
 
Infection of Mice.
 
5–6-wk-old C57BL/6 male mice were pur-
chased from The Jackson Laboratory (Bar Harbor, ME). For viral
infection, mice were injected intraperitoneally with 4 
 
3
 
 10
 
4
 
 PFU
of LCMV or 3 
 
3
 
 10
 
6
 
 PFU of PV in a 0.1-ml vol per mouse, or
intravenously with 2 
 
3
 
 10
 
7
 
 PFU of LCMV clone 13 in a 0.4-ml
vol per mouse. To reduce nonspecific T cell activation induced
by fetal bovine serum, LCMV and PV were diluted at 1:100 and
1:20, respectively, with phosphate-buffered saline before injec-
tion. For secondary LCMV infection, the immune mice at 6–7
wk after infection, before neutralizing antibodies were signifi-
cantly induced (18), were injected intraperitoneally with 10
 
7
 
 PFU
of LCMV in a 0.2–0.3-ml vol per mouse.
 
Spleen Cell Preparation and Sorting.
 
Spleen leukocytes were
prepared as described previously (19). To isolate CD8
 
1
 
V
 
b
 
8
 
1
 
cells, 10
 
8
 
 spleen cells were stained with 50 
 
m
 
l of anti-CD8 PE
(PharMingen, San Diego, CA) and 50 
 
m
 
l of anti-V
 
b
 
8.1/8.2
FITC (PharMingen) for 30 min on ice and washed twice with
RPMI 1640 (Sigma Chemical Co., St. Louis, MO) before sort-
ing. In some experiments CD4
 
1
 
 and CD8
 
1
 
 cells were isolated by
staining with 50 
 
m
 
l of anti-CD8 PE and 50 
 
m
 
l of anti-CD4 FITC
(PharMingen) before sorting. For staining, 10
 
6
 
 spleen cells were
mixed with anti-CD8 PE and anti-V
 
b
 
8.1/8.2 FITC, and then
fixed with 1% paraformaldehyde (J.T. Baker, Inc., Phillipsburg, 
1995
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NJ). After staining, cells were analyzed or sorted by flow cytome-
try using a FACSTAR
 
Ò
 
. Data analysis was performed using the
CELLQuest software (Becton Dickinson, San Jose, CA).
 
Antibody and Complement Depletion.
 
To deplete CD4
 
1
 
 cells,
spleen cells were incubated with anti-CD4 (GK1.5) for 45 min
on ice, washed once with RPMI 1640, and then incubated with
MAR 18.5 for 45 min on ice. The cells were washed once with
RPMI 1640, treated with rabbit complement H2 (Pel-Freez
Clinical Systems, Brown Deer, WI), and then incubated at 37
 
8
 
C
in a humidified 5% CO
 
2
 
 incubator for 45 min. At the end of the
incubation, the cells were washed three times with RPMI 1640.
 
Target Cell Preparation.
 
MC57G (H-2
 
b
 
), a methylcholanthrene-
induced fibroblast cell line from C57BL/6 mice, was propagated
in MEM (GIBCO BRL, Gaithersburg, MD) supplemented with
100 U/ml of penicillin G, 100 
 
m
 
g/ml streptomycin sulfate, 2 mM
 
l
 
-glutamine, 10 mM Hepes (United States Biochemical Corp.,
Cleveland, OH), and 10% heat-inactivated (56
 
8
 
C, 30 min) fetal
bovine serum (Sigma Chemical Co.). The TAP-2–deficient cell
line RMA-S (H-2
 
b
 
) was from Hans-Gustaff Ljunggren (Karolin-
ska Institute; Stockholm, Sweden) and was grown in RPMI
1640, supplemented as above. To prepare target cells, MC57G
cells were infected with LCMV or PV at a multiplicity of infec-
tion of 0.1 PFU/cell and incubated for 2 d at 37
 
8
 
C. RMA-S cells
were pulsed overnight with 200 
 
m
 
M of LCMV peptide glyco-
protein 33 (GP33), GP276, or nucleoprotein 396 (NP396), as
described previously (20).
 
Cytotoxicity Assays.
 
Cell-mediated cytotoxicity was deter-
mined by using a standard microcytotoxicity assay (21). In brief,
target cells were pelleted and resuspended in 100 
 
m
 
Ci of Na
 
51
 
Cr
(DuPont-NEN, Boston, MA) per 10
 
6
 
 cells and incubated at 37
 
8
 
C
in a humidified 5% CO
 
2
 
 incubator for 1 h. They were washed
three times with media, resuspended to 5 
 
3
 
 10
 
4
 
/ml, and 0.1 ml
was added to round-bottomed microtiter wells (Falcon Labware,
Becton Dickinson & Co., Oxnard, CA). Varying numbers of ef-
fector cells were added in 0.1-ml vol to achieve the desired E/T
ratios. For a spontaneous 
 
51
 
Cr-release control, 0.1 ml of media
was substituted for effector cells. Maximum release was deter-
mined by adding 0.1 ml of 1% NP-40 (United States Biochemical
Corp.) to the target cells. After 6 h at 37
 
8
 
C, the plates were cen-
trifuged at 200 
 
g
 
 for 5 min, and 0.1 ml of supernatant was re-
moved from each well and counted on a gamma counter (model
5000; Beckman Instruments Inc., Palo Alto, CA). Data were pre-
sented as: 
 
percent specific 
 
51
 
Cr-release
 
 
 
5
 
 100 
 
3
 
 [(
 
experimental cpm
 
 
 
2
 
spontaneous cpm
 
)/(
 
maximum release cpm
 
 
 
2
 
 
 
spontaneous cpm
 
)].
 
Oligonucleotides and Labeling.
 
The V
 
b
 
8.1, V
 
b
 
8.2, C
 
b
 
, and J
 
b
 
primer sequences were derived from a previous report by Panne-
tier et al. (22). V
 
b
 
8.1 and C
 
b
 
 primers used for RT-PCR reac-
tions and unlabeled J
 
b
 
 primers were synthesized by BioSynthesis
(Lewisville, TX). For 
 
33
 
P-labeling, J
 
b
 
 primers were labeled by us-
ing T4-polynucleotide kinase (Boehringer Mannheim, Mann-
heim, Germany) and [
 
g
 
-
 
33
 
P]ATP (DuPont-NEN). Fluorescent
J
 
b
 
 primers were synthesized and labeled at the 5
 
9
 
 end with fluo-
rophores (6-Fam, Hex, or Ned) by PE (Applied Biosystems, Inc.,
Foster City, CA). These fluorescent dye–labeled oligonucleotides
were purified by high performance liquid chromatography by the
manufacturer to remove the unlabeled oligonucleotides and un-
reacted dyes.
 
RNA Extraction.
 
Total RNA was extracted from spleen cells,
peritoneal exudate cells (PEC), and peripheral blood (PB) by the
acid-guanidinium thiocyanate-phenol-chloroform method (23).
In brief, 
 
,
 
10
 
7
 
 spleen cells or PEC were pelleted and subsequently
extracted with 0.5 ml of solution D (4 M guanidinium thiocya-
nate, 25 mM sodium citrate, 0.5% sarcosyl, and 1% 2-mercapto-
ethanol) (Sigma Chemical Co.), 50 
 
m
 
l of 2 M sodium acetate, pH 4
(Sigma Chemical Co.), 0.5 ml phenol, pH 8 (United States Bio-
chemical Corp.), and 0.1 ml chloroform (EM Science, Gibbs-
town, NJ)/isoamyl alcohol (Fisher Scientific Co.) (49:1). After a
15-min incubation on ice, the reaction mixture was centrifuged
at 10,000 
 
g
 
 for 20 min. The aqueous phase was transferred and
subjected to two cycles of precipitation with 2-propanol (Fisher
Scientific Co.). For PB samples, 0.25 ml PB (without anticoagu-
lant) was mixed with 0.5 ml solution D and 75 
 
m
 
l 2 M sodium
acetate and subjected to RNA extraction as described above.
When RNA was extracted from a small amount of lymphocytes
such as PB RNA samples were washed twice with 70% ethanol
after propanol precipitation to remove excess salt, which other-
wise would inhibit the RT-PCR reaction.
 
CDR3 Length Spectratyping.
 
RNA samples, equivalent to 5–10 
 
3
 
10
 
5
 
 cells or 0.12 ml of blood, were amplified by using a GeneAmp
RNA PCR kit (Perkin-Elmer Corp., Branchburg, NJ) with
V
 
b
 
8.1 and C
 
b
 
 primers, according to the manufacturer’s instruc-
tions. The amplification started with a denaturing step of 1 min at
94
 
8
 
C, followed by 40 cycles consisting of 1 min at 94
 
8C, 1 min at
558C, and 1 min at 728C, and a 5-min incubation at 728C to
complete the product extension. Although our primer sequences
were derived from those published by Pannetier et al. (22), our PCR
cycle profile was modified to optimize the amplification of PB sam-
ples. Nevertheless, the CDR3 spectratype remained the same
when splenic RNA was amplified by either condition. To deter-
mine whether lowering the annealing temperature to 558C
would cause a cross-reaction with the Vb8.2 sequence, the
splenic RNA of an HY transgenic mouse (24), which expresses
the Vb8.2 transgene in all T cells, was tested. Some cross-reaction
did occur when samples were amplified at the 558C or 608C an-
nealing temperature, but this cross-reaction at the 558C annealing
temperature contributed to ,3% of the Vb8.1 message during
the acute LCMV infection.
2 ml of the amplified PCR products was subjected to either
one cycle of run-off with radiolabeled Jb primers or five cycles of
run-off with fluorophore-labeled Jb primers in a final volume of
10 ml reaction mixture containing 50 mM KCl, 10 mM Tris-
HCl, pH 8.3, 1 mM MgCl2, 200 mM dNTP, 0.25 U Taq poly-
merase (Perkin-Elmer Corp.), and 0.1 mM of labeled Jb primers.
2 ml of the radioactive products was mixed with equal volumes of
gel-loading buffer (95% formamide, 20 mM EDTA, 0.05% bro-
mophenol blue, 0.05% xylene cyanol FF) and loaded on 5% Long
Ranger sequencing gels (FMC Bioproducts, Rockland, ME); 1 ml
of the fluorescent products was mixed with an equal volume of
gel-loading buffer (5 parts of 100% formamide and 1 part of 2.5%
blue dextran/50 mM EDTA) and loaded onto a 4.75% acryla-
mide sequencing gel. For radioactive products, the gels were ex-
posed to a phosphor screen, and the radioactive intensity of each
band was quantified by a PhosphorImager (Molecular Dynamics,
Sunnyvale, CA). For fluorescent products, the results were ana-
lyzed on an automated DNA sequencer using GeneScan software
(Perkin-Elmer Applied Biosystems, Emeryville, CA). Both radio-
labeled and fluorescent-labeled methods gave comparable results.
However, the fluorescent-labeled method was easier and more
efficient because fluorescent-labeled primers are stable and run-
off products labeled with three different fluorescent dyes can be
analyzed in the same gel lane. Therefore, we changed our tech-
nique from the radiolabeled method to fluorescent-labeled
method in the middle of our study, when the fluorescent-labeled
method became available at our institution.
Direct Sequencing of PCR Products. RT-PCR products in 30–
75 ml were purified by using a QIAquick PCR purification kit1996 Lymphocytic Choriomeningitis Virus–induced TCR Repertoire
(QIAGEN Inc., Santa Clarita, CA) and subjected to DNA se-
quencing by using specific unlabeled Jb primer and a Dye Termi-
nator Cycle Sequencing kit (Perkin-Elmer, Foster City, CA).
The sequencing products were run through 4.75% sequencing
gels and analyzed on an automatic DNA sequencer (model 373;
PE Applied Biosystems).
Statistical Analysis. To determine the significance of the pres-
ervation of a dominant peak in the memory response, we com-
pared the proportion of the peak within that specific Jb spec-
tratype in the immune mouse with that of a comparable peak in
naive mice. Because the naive spectratypes invariably have a nor-
mal Gaussian distribution, the mean and standard deviations of
the peak within a certain Jb spectratype were calculated from five
naive mice. The preservation of a significant dominant peak in
memory was defined as those peaks whose proportions exceeded
the mean of naive mice by .2 SD.
Results
Vb8 Usage in LCMV Infection. To study the evolution
of TCR repertoire usage in LCMV infection, we chose to
analyze the Vb8 TCR, because it is expressed on a signifi-
cant number of T cells in the C57BL/6 mouse (4), and be-
cause the LCMV-specific lysis is highly represented within
the Vb8 population (19). As shown in Fig. 1, acute LCMV
infection expanded the CD81Vb81 cells from 3 to 16% of
spleen cells or from 20 to 30–35% of total CD81 cells.
Therefore, the CD81Vb81 cells contributed greatly to the
major expansion of the CD81 population during acute
LCMV infection. To characterize the specificity of these
CD81Vb81 cells, we tested their cytolytic activities against
targets infected with LCMV or with the heterologous vi-
rus, PV. As shown in Table 1, the CD81Vb81 cells in-
duced during the acute LCMV infection specifically lysed
LCMV-infected but not PV-infected targets. The CD81
Vb81 cells also specifically lysed RMA-S cells pulsed with
LCMV peptides GP33, GP276, and NP396. We have re-
ported previously that RMA-S cells pulsed with peptides
from other viruses are lysed much less by LCMV-induced
T cells (20). Interestingly, enrichment of specific CTL ac-
tivities against all three LCMV immunodominant epitopes
was detected within the CD81Vb81 cells, indicating that
this subset of T cells is useful for examining the dynamics of
Figure 1. Vigorous expansion of CD81Vb81 cells during acute
LCMV infection. 6–8-wk-old C57BL/6 mice were inoculated intraperi-
toneally with 4 3 104 PFU of LCMV. Spleen cells were harvested at var-
ious time points after LCMV infection, and stained with anti-CD8 PE
and anti-Vb8.1/8.2 FITC, and analyzed by flow cytometry. Cell percent-
ages for quadrants (clockwise from upper left) were: (day 0) 12, 3, 10, 75;
(day 6) 13, 7, 8, 72; (day 9) 35, 16, 13, 36; (day 12) 25, 10, 14, 51; and
(day 64) 13, 4, 8, 75.
Table 1. Enrichment within the CD81Vb81 Population of Specific CTL Activity against 3 LCMV Immunodominant Epitopes
EXPT Targets
% Specific lysis
Effector cells (E/T ratio)*
CD81Vb81 CD81Vb82 Unsorted
20 10 5 20 10 5 100 50 25
1. LCMV-infected MC57G 51 32 26 36 28 17 60 59 40
PV-infected MC57G 2 3 1 1 1 21 22 22 24
MC57G 2 1 21 21 24 23 22 22 22
2. GP33-pulsed RMA-S 89 70 57 75 62 49 91 75 51
GP276-pulsed RMA-S 70 61 45 55 39 28 83 62 41
NP396-pulsed RMA-S 98 90 74 70 67 49 98 88 70
RMA-S 0 0 2200 221 210
Specific lysis mediated by each population of T cells against infected or peptide-coated targets was determined in a 6-h 51Cr-release assay. Spleen cells
from C57BL/6 mice at 9 d after infection with LCMV were sorted by FACSÒ to obtain CD81Vb81 cells. The purities of the sorted CD81Vb81
and CD81Vb82 cells in EXPT 1 were 85 and 98%, and those in EXPT 2 were 90 and 98%, respectively.
*The numbers under each effector cell type represent the effector to target ratio used.1997 Lin and Welsh
a complex T cell response directed against several epitopes
(Table 1).
We next examined the contribution of the Vb8.1 and 8.2
subsets to the expansion of the Vb8 population during acute
LCMV infection by using RT-PCR with the Vb8.1- and
8.2-specific primers in combination with the Cb primer. A
much stronger band was detected when the acute LCMV-
infected splenic RNA was amplified with the Vb8.1 and
Cb primers (data not shown). Thus, analysis of the Vb8.1
TCR usage would shed light on the evolution of a signi-
ficant part of the LCMV-induced T cell repertoire.
Similar Spectratypes Are Detected in Spleen, PB, and PEC
within an Individual Mouse. To determine the LCMV-
induced Vb8.1 TCR repertoire usage directly ex vivo, we
analyzed the TCR usage by CDR3 length spectratyping.
Pilot experiments were performed by using five Jb primers
to determine the spectratype during acute LCMV infec-
tion. Whereas naive mice generated the typical Gaussian
distribution (see Fig. 5, day 0), spectratypes were skewed in
LCMV-infected mice (Figs. 2 and 3). The LCMV-induced
splenic spectratypes were different among individual mice,
although there were some similarities. To confirm that the
variation between spectratypes was due to the differences
of TCR usage among individual mice instead of problems
with the reproducibility of the technique, we took two dif-
ferent RNA samples and performed spectratyping in tripli-
cates, beginning with separate RT-PCR reactions. The
spectratypes were highly reproducible within each RNA
sample (data not shown).
Because the spectratypes varied between individual
mice, studies on the evolution of the repertoire necessitated
following the same individual mice longitudinally during
Figure 2. Similar CDR3 pro-
files of the Vb8.1-Jb run-off
products from acute LCMV-
infected spleen, PB, and PEC
within a mouse. Total RNAs
were extracted from spleen leu-
kocytes, PB, and PEC 8 d after
LCMV infection and subjected
to spectratyping as described in
Materials and Methods. Radio-
activity intensity (y-axis) was
plotted against relative CDR3
size (x-axis).
Figure 3. Host diversity in the broad spectrum of Vb8.11 T cell response as demonstrated by complete CDR3 size analysis within the Vb8.11 cells
from day 8 LCMV-infected mice. CDR3 size patterns were obtained from day 8 LCMV-infected PBL from four C57BL/6 mice. Total RNAs from the
PB were extracted and subjected to spectratyping as described in Materials and Methods. The PCR products were subjected to run-off reactions using
[g-33P]ATP-labeled (A) or fluorescent (B) Jb primers. Jb1.3 and Jb1.6 were labeled with the fluorescent dye Ned; Jb1.4 and Jb2.5 with 6-Fam; Jb1.5,
Jb2.3, and Jb2.7 with Hex. Because primers labeled with different fluorophores give different fluorescent intensity, it is not appropriate to compare the
relative fluorescent intensity between different fluorophore-labeled run-off products. The magnitude of fluorescent intensities is 6-Fam . Hex . Ned.1998 Lymphocytic Choriomeningitis Virus–induced TCR Repertoire
LCMV infection, as a comparison of spectratypes between
the mice would be impossible to interpret. This could only
be done by examining PB spectratypes, as examining
spleen cell spectratypes would require killing the mice. To
see whether the PB spectratypes were representative of
those in other immunological compartments, we compared
the spectratypes in spleen, PB, and PEC after LCMV infec-
tion and found them to be nearly identical (Fig. 2). Fig. 2
shows the spectratypes for day 8 after infection, and spec-
tratypes similar for spleen, PB, and PEC were also observed
at days 6 and 12 after infection (data not shown). Thus, it
was feasible to study the evolution of TCR repertoire
usage in LCMV infection by determining the PB spec-
tratype.
Acute LCMV Infection Expands a Broad Spectrum of
Vb8.11 T Cells. To examine the complete Vb8.11 T
cell repertoire in acute LCMV infection, we analyzed the
Vb8.1 spectratypes with primers specific to all 12 Jbs. The
Vb8.1 spectratypes from naive mice at 6 wk and 4 mo of
age invariably had a normal Gaussian distribution for each
of the Jbs (data not shown). In contrast, the acute LCMV
infection expanded a broad spectrum of Vb8.11 T cells.
Dominant peaks were consistently detected in the spec-
tratypes of Jbs 1.1, 1.2, 1.3, 1.5, and 1.6 in most of the
mice tested; some other peaks occasionally were detected
in the Jb2s (Fig. 3; The two types of graphic displays reflect
the fact that some analyses used 33P-labeling [Fig. 3 A] and
others, done later in the study, used fluorescent labeling
[Fig. 3 B]). The spectratypes determined by Jbs 2.2 and 2.4
were consistently very weak, as the radioactivity intensities
(Y-axes) were low in both acutely infected and naive mice.
Thus, genetically identical hosts generate somewhat pre-
dictable but nevertheless different T cell spectratypes in re-
sponse to the same virus. Of the 12 Jbs, Jb1s were prefer-
entially used. This preferential expansion was elicited by
the virus infection and not by the diluted culture media ve-
hicle, as the spectratype from vehicle-injected mice had a
normal Gaussian distribution (data not shown). The Vb8.1
spectratype in acute PV infection, which also activated
Vb81 T cells, although to a lesser extent, was unlike that
observed in the acute LCMV infection, as PV infection did
not generate consistent dominant peaks in the spectratypes
of Vb8.1-Jb1.1 and Vb8.1-Jb1.2 (data not shown). The
observation of discrete LCMV-induced clonal expansion
by spectratyping indicates that the massive proliferation of
T cells within the Vb8.1 population is unlikely due to
LCMV-encoded superantigen stimulation or nonspecific
cytokine stimulation.
The Skewed Vb8.1 Spectratype Is Dominated by the CD81
T Cell Population. To evaluate the contribution of the
CD41 and CD81 T cell populations to the skewed Vb8.1
spectratype during acute LCMV infection, we depleted
CD41 T cells from the spleen cells at 9 d after LCMV in-
fection and compared the spectratype of the CD4-depleted
spleen cells to that of the total spleen cells. As shown in Fig.
4, experiment 1 (EXPT. 1), the spectratype of the CD4-
depleted spleen cells was very similar to that of the total
spleen cells, indicating that CD41 T cells contribute little
to the skewed Vb8.1 spectratype. We also sorted CD41
and CD81 T cells from the spleen cells at 8 d after LCMV
infection and determined their Vb8.1 spectratype. The
CD8 spectratype was nearly identical to that of the un-
sorted spectratype (Fig. 4, EXPT. 2). Even though re-
sponses could be seen within the Jb1.2 and Jb1.3 CD4
spectra, in the total T cell population they were not suffi-
cient to influence the more dominant response associated
with the CD81 cells. Taken together, the skewed Vb8.1
spectratype is dominated by the CD81 T cell population,
and studies of the LCMV-induced Vb8.1 spectratype by
using PB or spleen reflect mainly the LCMV-induced CD8
spectratype.
The Vb8.1 Spectratype Changes Little during the Apoptosis
Phase of the T Cell Response. The fact that LCMV-induced
spectratypes differed between individual mice indicated
that studies on the evolution of the T cell response could
not be done by comparison of one mouse to another, but
instead required longitudinal studies within the same
mouse. We were able to do this by examining PB spec-
tratypes. From days 10 to 14 after infection, a time period
immediately after the peak in the massive CD81 T cell
proliferation, the majority of the T cells undergo apoptosis
in vivo (11). Most virus is cleared by z7 d after infection,
and we asked whether there is a further selection of T cell
receptors after viral clearance and during this apoptosis
phase. Fig. 5 shows the PB spectratype from individual
mice at days 6 to 12 after infection and compares it with
Figure 4. Skewed Vb8.1 spectratypes within CD81 T cells during
acute LCMV infection. (EXPT. 1) Spleen cells from a C57BL/6 mouse at
9 d after LCMV infection were depleted of CD41 T cells as described in
Materials and Methods. 0.5% of CD41 T cells were left after CD4 deple-
tion. (EXPT. 2) Spleen cells from a C57BL/6 mouse at 8 d after LCMV
infection were sorted by FACSÒ to obtain CD41 or CD81 T cells. The
purities of the sorted CD41 or CD81 T cells were 98 and 99%, respec-
tively. Total RNA was extracted from each population of T cells and sub-
jected to spectratyping.1999 Lin and Welsh
the normal Gaussian distribution pattern of separately ex-
amined uninfected mice. The naive spectratype began to
change by day 5 (data not shown) and evolved into a dis-
tinct spectratype by day 8 after infection. This distinct spec-
tratype remained stable from days 8 to 12 after infection,
even though there was a significant decrease in the number
of T cells after day 9. This suggests that after viral antigens
are cleared, further selection of the T cell repertoire does
not occur during the T cell apoptosis period.
Sequence Analyses Show Stability of the TCR Repertoire
within an Individual Mouse but Distinctions among Mice. To
determine whether a discrete spectratype peak was pre-
dominantly monoclonal and whether a further selection of
the TCR sequences occurred from days 8 to 12 after
LCMV infection, we directly sequenced PCR DNA am-
plified from day 8 and day 12 LCMV-infected PBL (Fig. 5)
by using Jb primers that had revealed singular and domi-
nant spectratype bands. Fig. 6 shows that this technique
revealed predominantly monoclonal TCR sequences in
some mice. The sequences of mouse 4 were monoclonal,
whereas the sequences in mice 1 and 3 each appeared to
reveal two clones. The sequences in the CDR3 region re-
mained unchanged from days 8 to 12 after LCMV infec-
tion in mice 1, 3, and 4. In mouse 2, it was hard to draw
any conclusion by comparing the sequences between day 8
and day 12 of LCMV infection because too many unread-
able sequences were present in the CDR3 region, indicat-
ing that several clones were present. Surprisingly, the DNA
sequences were very different among these four mice even
though they had a very similar Jb1.6 spectratype with dis-
crete, similarly sized bands. Notably, a conserved GXXN
amino acid motif with a non-V, non-J–encoded glycine
residue at position 96 was detected in all the sequences an-
alyzed, even those from the multiclonal mouse 2, suggest-
ing the importance of this motif for the recognition of
LCMV. These DNA sequence data further support the
concepts that genetically identical hosts generate different
Figure 5. Preservation of Vb8.1 spectratypes during the
T cell apoptosis phase from days 8 to 12 after LCMV infec-
tion. The representative CDR3 profiles from the PB of
four acutely LCMV-infected mice 6–12 d after infection
are displayed. Since the naive spectratypes invariably have a
normal Gaussian distribution, we plot at the top of each
column day 0 spectratypes from two naive control mice.
To avoid traumatizing the mice at the time of LCMV in-
fection, day 0 samples were not taken from the same mice
analyzed on the subsequent days. The PCR products were
subjected to run-off reactions using [g-33P]ATP-labeled
(Jb1.1 and Jb1.2) or fluorescent (Jb1.3, Jb1.5, and Jb1.6)
Jb primers.
Figure 6. Stability of TCR se-
quences after viral clearance.
DNA sequences and deduced
amino acid sequences of the
Vb8.1-Jb1.6 and Vb8.1-Jb1.5
were derived from direct se-
quencing of PCR DNA. The
sequences shown represent the
deduced amino acid sequences of
the VDJ junctions beginning
with residue 92 (33) of the am-
plified PCR products that were
rearranged to the Jb1.5 and
Jb1.6 gene segments. PCR
products were amplified from the same individual mice at various time
points after LCMV infection and then subjected to spectratyping. Discrete
spectratype peaks were selected for direct DNA sequencing as described
in Materials and Methods. The d8 and d12 DNA sequences from mice 1–4
were derived by using the same PCR products used for spectratyping in
Fig. 5. At some positions it was clear from the DNA sequence data that
either of two amino acids were encoded by what were probably two
clones, and these are designated in the A/B format. The unreadable DNA
sequences and amino acid translation in mouse 2 were designated N and
X, respectively.2000 Lymphocytic Choriomeningitis Virus–induced TCR Repertoire
T cell responses to the same antigen and that after 7 d of
LCMV infection, when virus is cleared, no further selec-
tion of the T cell repertoire occurs.
The Vb8.1 Spectratype Changes Continuously from 7 to 13 d
under Conditions of Clonal Exhaustion by High Doses of
LCMV Clone 13 Infection. A high dose LCMV clone 13
infection results in a transient antiviral CTL response fol-
lowed by clonal exhaustion of the virus-specific T cells,
due to the overwhelming amount of antigen present (7).
We asked how global the T cell exhaustion was by exam-
ining the Vb8.1 spectratype. As shown in Fig. 7 A, the
spectratype changed continuously from 7 to 13 d after
LCMV clone 13 infection, when excess viral antigens were
present. Some dominant peaks in the Vb8.1 spectratype
disappeared at days 10 or 13 after infection: mouse 1 Jb1.1,
mouse 3 Jb1.2, mouse 4 Jb1.3, mice 1 and 4 Jb1.5, and
mouse 3 Jb1.6. Others changed from 7 to 13 d after infec-
tion, accompanied with new peak formation: mouse 2
Jb1.1, and mice 2 and 4 Jb1.6. However, others remained
stable, such as those of mice 1 and 4 Jb1.2, mouse 3 Jb1.3,
and mouse 1 Jb1.6. To determine whether all of the virus-
induced CD81 T cells were clonally exhausted and whether
the skewed spectratype was due exclusively to CD41 T
cells, we sorted CD41 and CD81 cells from the spleen cells
at 13 d after LCMV clone 13 infection to determine their
Vb8.1 spectratype. As shown in Fig. 8, skewed spectratypes
were detected in both CD41 and CD81 T cell popula-
tions. Therefore, the change of spectratype from 7–13 d af-
ter LCMV clone 13 infection was not due to selective pres-
ervation of the CD41 T cell population.
To investigate whether a subset of T cells activated by
high dose clone 13 infection was resistant to clonal exhaus-
tion and survived in persistent infection, we examined the
Vb8.1 spectratype during longer term infections. Although
we still detected skewed Vb8.1 spectratypes at day 15 and,
to a lesser extent, at day 22 after infection (data not shown),
almost all of the spectratypes became like those of naive
mice by 42 d after infection and remained the same there-
after (Fig. 7 B). Only very weak non-Gaussian spectratypes
could sometimes be detected, such as that of Jb1.6 in
mouse 5 (Fig. 7 B). This observation suggests that most
clone 13–induced T cells eventually underwent clonal ex-
haustion. In summary, these results support the concept
that continuous selection of T cells occurs in the presence
of persistent antigens, but they also show that T cell clonal
exhaustion occurs in the great majority of the virus-
induced T cells, and only very weak T cell responses can be
detected long after infection.
The LCMV-immune Spectratype Is Different from the Naive
Spectratype but Resembles That of Acute Infection. It has not
been known which activated T cells and what proportions of
these T cells survive the apoptosis phase and become mem-
ory cells. Our LDA data indicate that there is only a two-
fold reduction in the numbers of LCMV-specific pCTL
per CD81 cell between the peak of the acute infection and
long term memory. The efficiencies of these assays, which
indicate that z2% of the CD81 T cells are precursors for
LCMV-specific CTL in immune mice, are unknown, and
a much higher proportion of the T cells in the immune
Figure 7. Evolution of the Vb8.1 spectratypes under conditions of
clonal exhaustion by high doses of LCMV clone 13 infection. (A) Con-
tinuous change from days 7 to 13 in Vb8.1 spectratypes was detected in
high dose LCMV clone 13 infection. The representative CDR3 profiles
from the PB of four LCMV clone 13–infected mice are displayed. (B)
Loss of skewed Vb8.1 spectratypes was detected after long term clone 13
infection. The representative CDR3 profiles from the PB of two LCMV
clone 13–infected mice are displayed. The PCR products were subjected
to run-off reactions using fluorescent Jb primers.
Figure 8. Skewed Vb8.1 spectratype within CD81 T cells under con-
ditions of clonal exhaustion by high dose LCMV clone 13 infection. The
representative CDR3 profiles were obtained from PB and sorted spleen
cells at 13 d after LCMV clone 13 infection. The spleen cells were sorted
by FACSÒ to obtain CD41 and CD81 T cells. The purities of the sorted
CD41 and CD81 T cells were 88 and 95%, respectively. Total RNA was
extracted from each population of T cells and subjected to spectratyping.2001 Lin and Welsh
state may be specific for the virus than previously thought.
A recent study on tetrameric MHC–peptide staining of
TCR supports the concept that a substantial number of
memory cells remain virus specific (13). To determine the
preservation and distribution of virus-induced T cell spe-
cies in the memory state, we compared the Vb8.1 spec-
tratype in the acute LCMV infection with that in the im-
mune state from the same individual mice. The immune
spectratype (Fig. 9 A, day 42; Fig. 9 C, 2–2.5 mo) was very
different from the naive spectratype but resembled a com-
bination of that of acutely infected and naive mice, consis-
tent with only a moderate dilution of memory cells with
naive cells (Fig. 9 A). This supports the concept that
LCMV infection alters the host T cell repertoire dramati-
cally and leaves it with a high frequency of LCMV-specific
T cells (9). We found that very dominant peaks in the
acute infection often remained present in the immune
state. Six dominant peaks consisting of z70% of the T cells
in their specific Jb spectratypes were selected for sequence
analysis. By direct sequencing of the PCR DNA, we were
able to resolve a monoclonal sequence from one of the six
peaks. Its TCR sequence was identical to that seen at day
10 of the acute infection (Fig. 6), and, notably, it had the
same GXXN conserved motif seen in the acute Jb1.6 sam-
ples. It appears that very strong dominant peaks in the acute
infection, regardless of which Jb they use, can be detected
in the immune state by spectratyping.
Although pCTL data have shown that a high frequency
of LCMV-specific pCTL remains stable throughout the
lifetime of the mouse (1), it was still not clear how the
TCR repertoire evolved long after infection and whether
such a high frequency of pCTL reflected a drastic alteration
of the host T cell repertoire in long term memory. There-
fore, we examined the evolution of Vb8.1 TCR repertoire
into long term memory by spectratyping. As shown in Fig.
9  B, dominant peaks were stably preserved from acute
LCMV infection through 7 mo after infection, and during
this period of time no other new peaks were generated.
Figure 9. Evolution of the
Vb8.1 spectratypes from primary
LCMV infection into memory
and secondary responses. (A)
The LCMV-immune Vb8.1
spectratype resembled that of
acute infection, and most of the
primary spectratypes were pre-
served during secondary infec-
tion. CDR3 profiles were ob-
tained from PB of two individual
mice at days 10 (D10) and 42
(D42) after primary LCMV in-
fection and at day 5 after second-
ary infection. Day 0 spectratypes
were obtained from two differ-
ent naive controls. The run-off
reactions were primed with ra-
diolabeled (Jb1.1,  Jb1.2, and
Jb2.1) or fluorescent (Jb1.5 and
Jb1.6) Jb primers. The signifi-
cance of the preservation of
dominant peaks in the immune
state was determined as described
in Materials and Methods. In this
figure, all of the dominant peaks
except those of Jb1.1, Jb1.2, and
Jb1.6 from PB 1 remained
skewed in memory. In secondary
infection, some newly formed
peaks such as those of Jb1.5 in
PB 1 and PB 2, and Jb1.6 in PB 1
are marked with asterisks. (B)
Dominant peaks were preserved
from acute LCMV infection into
long term memory. Representa-
tive CDR3 profiles were ob-
tained from PB of one mouse at
day 10 (D10), 4 mo (4MO), and
7 mo (7MO) after LCMV infec-
tion. In this figure, the Jb1.2 and
Jb1.6 spectratypes were significantly preserved into 7 mo after infection. (C) Skewed Vb8.1 spectratypes were detected in LCMV-immune PEC. CDR3
profiles were obtained from PB of acutely LCMV-infected and from LCMV-immune spleen leukocytes, PB, and PEC. Total RNA was extracted from
PB of day 10 (D10 PB) LCMV-infected mice and from LCMV-immune spleen leukocytes (SPLEEN), PB (PB), and PEC (PEC) of two immune mice
at 2–2.5 mo (2MO) after LCMV infection. The run-off reactions were primed with fluorescent Jb primers. The spectratypes were obtained from two dif-
ferent mice.2002 Lymphocytic Choriomeningitis Virus–induced TCR Repertoire
Thus, a high frequency of LCMV-induced T cells can be
preserved from acute infection into long term memory and
permanently skew the host T cell repertoire.
In the immune state, the spectratypes of PB and spleen
were similar to each other, but that of PEC was somewhat
different (Fig. 9 C) in that it even more closely resembled
that of the PB during the acute infection, which is consis-
tent with our previous findings that LCMV-immune PEC
contain a higher frequency of LCMV-specific pCTL (25).
This might be because the LCMV infection had been estab-
lished previously by i.p. inoculation or because few naive T
cells accumulate in the peritoneal cavity to dilute out the
memory cell population.
To determine the effects of secondary LCMV infection
on the spectratype, we rechallenged the immune mice with
a high dose of LCMV (107 PFU) and then analyzed their
Vb8.1 spectratypes. The LCMV-induced secondary spec-
tratype was similar in most of the dominant peaks but was
different in some, compared with that of the primary infec-
tion. Fig. 9 A shows that subdominant peaks, such as those
of Jb1.5 in mice 1 and 2 and that of Jb1.6 in mouse 1, ap-
peared in the secondary response for the first time. The further
selection of the TCR repertoire was not due to a nonspe-
cific activation induced by culture media, as the media-injected
LCMV-immune mice had a spectratype similar to that of
their immune state (data not shown). To confirm that the
secondary infection activated LCMV-specific T cells, we
examined CTL activities on the same day (day 5) as the
spectratype analyses after secondary LCMV infection. Sig-
nificant LCMV-specific CTL activities were detected (63%
specific lysis against LCMV-infected targets at E/T 5 200
in a direct ex vivo 6-h assay). These results support the
generally accepted concept that further maturation of the T
cell response can occur in a secondary viral infection.
Discussion
In this study we have provided evidence supporting the
concepts that (a) the virus-induced T cell repertoire during
a primary infection changes little after clearance of the viral
antigens; (b) it is continuously selected in the presence of
excess viral antigens leading to persistent infection; (c) the
LCMV infection substantially skews the host T cell reper-
toire in the memory state long after virus is cleared; and (d)
genetically identical mice generate somewhat predictable
but nevertheless remarkably different T cell responses to
the same antigens. Evidence supporting the first and second
concepts is that the LCMV-induced Vb8.1 spectratype
changes little between 8 and 12 d after LCMV infection, a
time when the virus has already been cleared (Fig. 5), but it
continues to evolve from 7 to 13 d after the infection of a
high dose of the clonally exhausting LCMV clone 13 (Fig.
7 A). Our spectratype data are consistent with our kinetic
studies on the pCTL frequencies, which show that the pro-
portions of the three LCMV immunodominant peptide–
specific pCTL become fixed within the LCMV-specific
repertoire by day 7 after infection, and thereafter remain
the same throughout the lifetime of the mouse (9). Al-
though a limitation of the spectratyping technique is that it
cannot detect subtle changes of the TCR usage within each
peak of the spectratype, our direct sequencing of the PCR
DNA revealed that the TCR sequences of the same-sized
dominant peaks within a specific Jb spectrum induced by
the parent LCMV strain remained stable between days 8
and 12 after infection (Fig. 6). In contrast, the spectratype
analyses showed that from 7 to 13 d after LCMV clone 13
infection the spectratypes changed continuously (Fig. 7 A);
such changes were not due to selective preservation of
CD41 T cells, as skewed spectratypes were detected in
both CD41 and CD81 T cell populations at 13 d after in-
fection (Fig. 8). The disappearance of the dominant peaks
from 7 to 10 d of the clone 13 infection paralleled the dele-
tion of the virus-specific CTL precursors; such a reduction
in pCTL was originally reported by Moskophidis et al. (7)
and confirmed by us during the course of these studies (26).
The appearance of new peaks and the stable presence of
other peaks from 7 to 13 d after clone 13 infection indi-
cated that some T cells remained activated instead of un-
dergoing clonal exhaustion during this period of time.
However, the majority of these T cells eventually under-
went clonal exhaustion long after the initial infection by
continuous stimulation with excess viral antigens, as most
spectratypes became like those of naive mice; only very
weakly skewed spectratypes could occasionally be detected
at 42 d after clone 13 infection (Fig. 7 B). Taken together,
these results suggest that no further selection of LCMV-
specific T cells occurs during the apoptosis phase in acute
LCMV infection, although a continuous selection of LCMV-
specific T cells does occur in the presence of excess viral
antigens in LCMV clone 13 infection.
A previous, unresolved question was to what degree the
specific immune response contracts after a systemic virus infec-
tion. Our spectratype data show that the LCMV infection
substantially skews the host T cell repertoire in the memory
state, as dominant peaks from the acute infection remain
present. The immune spectratype 6–8 wk after infection is
very different from that of naive mice, but resembles the com-
bination of that of acutely infected and naive mice (Fig. 9 A).
Thus, a host’s T cell repertoire can be substantially altered by a
virus infection, and remains skewed after the virus has been
cleared. This molecular analysis is consistent with previous ob-
servations revealed by LDA and by quantification of transgenic
T cells showing that LCMV infection leaves the host T cell
repertoire with a very high frequency of LCMV-specific T
cells (9, 12, 27), a claim also supported by a recent report on
MHC-tetramer binding studies. However, here we have been
able to show how a multiclonal T cell repertoire evolves from
acute infection and is preserved in the memory state.
pCTL data have shown that the frequency of the
LCMV-specific pCTL remains stable throughout the life-
time of the mouse (9, 12). In this study, we have examined
the preservation of the LCMV-induced Vb8.1 spectratype
up to 7 mo after infection. We found that the relative in-
tensity of a dominant peak within that specific spectrum
was weaker at 4 mo than at 6–7 wk after LCMV infection
(data not shown), but thereafter remained stable at least2003 Lin and Welsh
through 7 mo of infection (Fig. 9 B). This may reflect the
ability of RT-PCR to measure mRNA levels, which were
probably reduced in the older memory cells, as incubation
of the immune spleen cells or PB leukocytes with IL-2 rap-
idly revealed a spectratype similar to that of the acute infec-
tion (data not shown).
A broad spectrum of Vb8.11 T cells was activated dur-
ing acute LCMV infection (Fig. 3). A previous report ex-
amining specific T cell clones to Epstein-Barr virus sug-
gested that an immunodominant epitope induced a broad
T cell repertoire and that a subdominant epitope induced a
more restricted T cell repertoire (28). The Vb81 T cells
recognize three LCMV immunodominant peptides (Table
1), so it is not surprising that a broad spectrum of T cells
were activated during acute LCMV infection. Since domi-
nant peaks in the acute infection are present in the immune
state, it also appears that a broad repertoire of LCMV-spe-
cific T cells can be selected into memory. Some CTL
clones isolated from LCMV-immune mice infected with
serologically unrelated viruses, such as vaccinia virus or PV,
cross-react between the two viruses (29). A broad spectrum
of LCMV-specific memory T cells enhances the probabil-
ity of having cross-reactive memory cell clones that can be
stimulated and expanded quickly in the event of a second
virus infection, thus providing protective immunity or in-
fluencing the pathogenesis of a second infection. Experi-
ments have, in fact, demonstrated that a history of LCMV
infection provides protective immunity against vaccinia virus,
PV, and murine cytomegalovirus by controlling the viral rep-
lication early in infection (1). This examination of the Vb8.1
TCR usage suggests that the majority of the dominant T cell
clones detectable by spectratyping is not eliminated during the
apoptosis phase and survive in the memory cell population.
The fact that the spectratypes of immune splenocytes and
PB resemble a combination of the spectratypes found in
these compartments of acutely infected and naive mice sug-
gests that virus-specific memory cells become diluted with
naive cells, a result consistent with our LDA analyses (9).
However, the immune PEC have a spectratype virtually
identical to that of the lymphoid compartments during the
acute infection, which is consistent with the observation that
immune PEC contained a very high frequency of LCMV-
specific T cells (25). This result could be due to the fact that
there is a lack of dilution of the memory cells with naive cells
in the peritoneal cavity. Alternatively, the LCMV-specific
memory T cells may be more likely to circulate back to the
initial peritoneal cavity inoculation site. It is also possible that
some viral antigens remain in the peritoneal cavity to pro-
vide continuous stimulation to the LCMV-specific T cells,
such that they express a higher level of TCR RNA.
A recent study of the functional fine specificity of the
LCMV-specific CTL response led Bachmann et al. (30) to
propose that many T cells were deleted from the repertoire
during the apoptosis phase of the primary LCMV infection.
Previously published LDA data (9) as well as our data here
showing that the spectratype and the examined TCR se-
quences remained stable during the apoptosis phase of the
primary infection (Figs. 5 and 6) are inconsistent with that
suggestion. However, they do not rule out the possibility
that weak T cell responses insufficient to register in LDA or
spectratype analyses were eliminated during this time pe-
riod. Nevertheless, our data would indicate that changes in
the T cell repertoire between the primary and secondary
infections are not a consequence of the apoptotic phase of
infection, but instead are due to the selective pressure of
antigen during secondary infection.
An observation that we found of great interest is that
even though genetically identical mice generate similar lev-
els of CTL responses against the LCMV immunodominant
peptides (9, 13), the TCR repertoire generating these re-
sponses differed from mouse to mouse (Fig. 3). Differences
in spectratypes were even seen in LCMV-infected, a/b
TCR-deficient mice reconstituted with a common pool of
euthymic mouse splenocytes, supporting the argument that
these differences were not caused by prior exposure to dif-
ferent antigens by the individual mice (data not shown).
C57BL/6 mice infected with the same dose of LCMV had
different spectratypes (Fig. 3). There was preferential Jb us-
age and some homogeneity in the CDR3 length, but se-
quence analysis of the same sized discrete Vb8.1-Jb1.6
spectratype peaks revealed different DNA sequences. Al-
though the DNA sequences were different, a conserved
GXXN amino acid motif was detected in all the sequences
analyzed, suggesting the importance of both the CDR3
length and this motif for the recognition of LCMV. Direct
sequencing of dominant spectratype bands may be a useful
technique to define conserved motifs associated with re-
gions of the TCR involved in binding to the peptide–
MHC complex. These observations are complementary to
that of Maryanski et al. (31), who found that each of the
mice immunized with the P815-CW3 cells displayed dis-
tinct but structurally similar CD81 TCR repertoires to the
HLA-CW3 170-179 epitope, in that they had similar
CDR3 length and displayed a conserved non-V, non-J–
encoded glycine residue. A stochastic effect may play an
important role in the differences of T cell responses to the
same antigens. The fact that genetically identical hosts gen-
erate different T cell responses to the same antigens may
help explain the variation of incidence in virus-induced au-
toimmune diseases in genetically identical hosts. For exam-
ple, z30% of the diabetes-resistant BB/Wor rats developed
diabetes after Kilham’s rat virus infection (32).
In summary, the data presented here indicate that genet-
ically identical hosts generate remarkably different T cell
responses to the same antigens and that studies on the evo-
lution of the T cell repertoire require following the same
individual hosts longitudinally during an antigenic chal-
lenge. Data from such a longitudinal study support the
concepts that the virus-induced T cell repertoire remains
stable both after clearance of the virus and during the apop-
tosis phase of the T cell response but evolves in the pres-
ence of the viral antigens, as shown in the clone 13 model
and during secondary LCMV infection. A multiclonal T
cell response induced during an infection is preserved into
memory and continues to markedly skew the host T cell
repertoire long after the virus has been cleared.2004 Lymphocytic Choriomeningitis Virus–induced TCR Repertoire
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